Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015
Authors: Christopher Troeger, Mohammad Forouzanfar, Puja C Rao, Ibrahim Khalil, Alexandria Brown, Scott Swartz, Nancy Fullman, Jonathan Mosser, Robert L Thompson, Robert C Reiner, Amanuel Abajobir, Noore Alam, Mulubirhan Assefa Alemayohu, Azmeraw T Amare, Carl Abelardo Antonio, Hamid Asayesh, Euripide Avokpaho, Aleksandra Barac, Muktar A Beshir, Dube Jara Boneya, Michael Brauer, Lalit Dandona, Rakhi Dandona, Joseph R A Fitchett, Tsegaye Tewelde Gebrehiwot, Gessessew Buggsa Hailu, Peter J Hotez, Amir Kasaeian, Tawfik Khoja, Niranjan Kissoon, Luke Knibbs, G Anil Kumar, Rajesh Kumar Rai, Hassan Magdy Abd El Razek, Muktar S K Mohammed, Katie Nielson, Eyal Oren, Abdalla Osman, George Patton, Mostafa Qorbani, Hirbo Shore Roba, Benn Sartorius, Miloje Savic, Mika Shigematsu, Bryan Sykes, Soumya Swaminathan, Roman Topor-Madry, Kingsley Ukwaja, Andrea Werdecker, Naohiro Yonemoto, Maysaa El Sayed Zaki, Stephen S Lim, Mohsen Naghavi, Theo Vos, Simon I Hay, Christopher J L Murray, Ali H Mokdad
Journal: The Lancet Infectious Diseases (2017)

BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2015 provides an up-to-date analysis of the burden of lower respiratory tract infections (LRIs) in 195 countries. This study assesses cases, deaths, and aetiologies spanning the past 25 years and shows how the burden of LRI has changed in people of all ages.MethodsWe estimated LRI mortality by age, sex, geography, and year using a modelling platform shared across most causes of death in the GBD 2015 study called the Cause of Death Ensemble model. We modelled LRI morbidity, including incidence and prevalence, using a meta-regression platform called DisMod-MR. We estimated aetiologies for LRI using two different counterfactual approaches, the first for viral pathogens, which incorporates the aetiology-specific risk of LRI and the prevalence of the aetiology in LRI episodes, and the second for bacterial pathogens, which uses a vaccine-probe approach. We used the Socio-demographic Index, which is a summary indicator derived from measures of income per capita, educational attainment, and fertility, to assess trends in LRI-related mortality. The two leading risk factors for LRI disability-adjusted life-years (DALYs), childhood undernutrition and air pollution, were used in a decomposition analysis to establish the relative contribution of changes in LRI DALYs.FindingsIn 2015, we estimated that LRIs caused 2·74 million deaths (95% uncertainty interval [UI] 2·50 million to 2·86 million) and 103·0 million DALYs (95% UI 96·1 million to 109·1 million). LRIs have a disproportionate effect on children younger than 5 years, responsible for 704 000 deaths (95% UI 651 000–763 000) and 60.6 million DALYs (95ÙI 56·0–65·6). Between 2005 and 2015, the number of deaths due to LRI decreased by 36·9% (95% UI 31·6 to 42·0) in children younger than 5 years, and by 3·2% (95% UI −0·4 to 6·9) in all ages. Pneumococcal pneumonia caused 55·4% of LRI deaths in all ages, totalling 1 517 388 deaths (95% UI 857 940–2 183 791). Between 2005 and 2015, improvements in air pollution exposure were responsible for a 4·3% reduction in LRI DALYs and improvements in childhood undernutrition were responsible for an 8·9% reduction.InterpretationLRIs are the leading infectious cause of death and the fifth-leading cause of death overall; they are the second-leading cause of DALYs. At the global level, the burden of LRIs has decreased dramatically in the last 10 years in children younger than 5 years, although the burden in people older than 70 years has increased in many regions. LRI remains a largely preventable disease and cause of death, and continued efforts to decrease indoor and ambient air pollution, improve childhood nutrition, and scale up the use of the pneumococcal conjugate vaccine in children and adults will be essential in reducing the global burden of LRI.FundingBill & Melinda Gates Foundation.